131Iodine-Anti B1 (Murine) Radioimmunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 131Iodine-Anti B1 (Murine) Radioimmunotherapy, covering 2012-04-17 to 2012-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies [Phase 2]